跳至主要内容
临床试验/TCTR20200605004
TCTR20200605004尚未招募2 期

Impact of vitamin D supplement in erectile dysfunction treatment with Phosphodiesterase type 5 inhibitor

faculty of medicine ramathibodi hospital, mahidol university, Thailand0 个研究点目标入组 60 人开始时间: 2020年6月5日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 80 Years(—)
性别
Male

入选标准

  • 1. Erectile dysfunction patients with IIEF 5 score < 21
  • 2. patient's willing to be including in this trial

排除标准

  • 1. patients who already have vitamin D supplement prior to trial
  • 2. patients who have bowel disease that disturb drug absorption including celiac disease, Crohn disease, cystic fibrosis
  • 3. patients who have drug or alcohol addiction
  • 4. patients who have psychosis
  • 5. patients who have CKD stage 4,5
  • 6. patients who have acute illness that need hospitalization
  • 7. patients who have contraindication for PDE5 inhibitor including
  • 7.1 recent cardiiovascular or cerebrovascular or arrthymia in past 6 month
  • 7.2 CHF NYHA class ≥ 2 or coronary a disease
  • 7.3 BP drop or BP > 170/100
  • 7.4 liver disease Child-Pugh score C or ESRD that need HD

研究者

发起方
faculty of medicine ramathibodi hospital&#44; mahidol university&#44; Thailand

相似试验